Industry: Medical Care
Published Date: 2024-01-17
Pages: 91 Pages
Report ld: 2297929
Request Sample
Customized Report
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
The global Liquid Formulations Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liquid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Formulations Drug Delivery.
MARKET SEGMENTATION
REPORT SCOPE
The Liquid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Formulations Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Formulations Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Suspensions
1.2.3 Solutions
1.3 Market by Application
1.3.1 Global Liquid Formulations Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Home Care Settings
1.3.3 Hospitals & Clinics
1.3.4 Burn Centers
1.3.5 Other Facilities
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Formulations Drug Delivery Market Perspective (2019-2030)
2.2 Liquid Formulations Drug Delivery Growth Trends by Region
2.2.1 Global Liquid Formulations Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liquid Formulations Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Liquid Formulations Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Liquid Formulations Drug Delivery Market Dynamics
2.3.1 Liquid Formulations Drug Delivery Industry Trends
2.3.2 Liquid Formulations Drug Delivery Market Drivers
2.3.3 Liquid Formulations Drug Delivery Market Challenges
2.3.4 Liquid Formulations Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid Formulations Drug Delivery Players by Revenue
3.1.1 Global Top Liquid Formulations Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Liquid Formulations Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Liquid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Formulations Drug Delivery Revenue
3.4 Global Liquid Formulations Drug Delivery Market Concentration Ratio
3.4.1 Global Liquid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Formulations Drug Delivery Revenue in 2023
3.5 Liquid Formulations Drug Delivery Key Players Head office and Area Served
3.6 Key Players Liquid Formulations Drug Delivery Product Solution and Service
3.7 Date of Enter into Liquid Formulations Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Formulations Drug Delivery Breakdown Data by Type
4.1 Global Liquid Formulations Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Liquid Formulations Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Liquid Formulations Drug Delivery Breakdown Data by Application
5.1 Global Liquid Formulations Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Liquid Formulations Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liquid Formulations Drug Delivery Market Size (2019-2030)
6.2 North America Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
6.4 North America Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid Formulations Drug Delivery Market Size (2019-2030)
7.2 Europe Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid Formulations Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Liquid Formulations Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid Formulations Drug Delivery Market Size (2019-2030)
9.2 Latin America Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid Formulations Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Detail
11.1.2 3M Business Overview
11.1.3 3M Liquid Formulations Drug Delivery Introduction
11.1.4 3M Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.1.5 3M Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Detail
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Liquid Formulations Drug Delivery Introduction
11.2.4 Merck & Co Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.2.5 Merck & Co Recent Development
11.3 Crescita Therpeautics
11.3.1 Crescita Therpeautics Company Detail
11.3.2 Crescita Therpeautics Business Overview
11.3.3 Crescita Therpeautics Liquid Formulations Drug Delivery Introduction
11.3.4 Crescita Therpeautics Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.3.5 Crescita Therpeautics Recent Development
11.4 Novartis International
11.4.1 Novartis International Company Detail
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Liquid Formulations Drug Delivery Introduction
11.4.4 Novartis International Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.4.5 Novartis International Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Liquid Formulations Drug Delivery Introduction
11.5.4 Boehringer Ingelheim Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Liquid Formulations Drug Delivery Introduction
11.6.4 Pfizer Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Detail
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Liquid Formulations Drug Delivery Introduction
11.7.4 Teva Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Detail
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb Liquid Formulations Drug Delivery Introduction
11.8.4 Bristol Myers Squibb Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.8.5 Bristol Myers Squibb Recent Development
11.9 Lead Chemical
11.9.1 Lead Chemical Company Detail
11.9.2 Lead Chemical Business Overview
11.9.3 Lead Chemical Liquid Formulations Drug Delivery Introduction
11.9.4 Lead Chemical Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.9.5 Lead Chemical Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Detail
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Liquid Formulations Drug Delivery Introduction
11.10.4 Purdue Pharma Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.10.5 Purdue Pharma Recent Development
11.11 Glenmark Pharmaceuticals
11.11.1 Glenmark Pharmaceuticals Company Detail
11.11.2 Glenmark Pharmaceuticals Business Overview
11.11.3 Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Introduction
11.11.4 Glenmark Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.11.5 Glenmark Pharmaceuticals Recent Development
11.12 Galderma
11.12.1 Galderma Company Detail
11.12.2 Galderma Business Overview
11.12.3 Galderma Liquid Formulations Drug Delivery Introduction
11.12.4 Galderma Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.12.5 Galderma Recent Development
11.13 Johnson & Johnson Private
11.13.1 Johnson & Johnson Private Company Detail
11.13.2 Johnson & Johnson Private Business Overview
11.13.3 Johnson & Johnson Private Liquid Formulations Drug Delivery Introduction
11.13.4 Johnson & Johnson Private Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.13.5 Johnson & Johnson Private Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Detail
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Liquid Formulations Drug Delivery Introduction
11.14.4 GlaxoSmithKline Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.14.5 GlaxoSmithKline Recent Development
11.15 Bausch Health Companies
11.15.1 Bausch Health Companies Company Detail
11.15.2 Bausch Health Companies Business Overview
11.15.3 Bausch Health Companies Liquid Formulations Drug Delivery Introduction
11.15.4 Bausch Health Companies Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.15.5 Bausch Health Companies Recent Development
11.16 Hisamitsu Pharmaceuticals
11.16.1 Hisamitsu Pharmaceuticals Company Detail
11.16.2 Hisamitsu Pharmaceuticals Business Overview
11.16.3 Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Introduction
11.16.4 Hisamitsu Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.16.5 Hisamitsu Pharmaceuticals Recent Development
11.17 Cipla
11.17.1 Cipla Company Detail
11.17.2 Cipla Business Overview
11.17.3 Cipla Liquid Formulations Drug Delivery Introduction
11.17.4 Cipla Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.17.5 Cipla Recent Development
11.18 Bayer
11.18.1 Bayer Company Detail
11.18.2 Bayer Business Overview
11.18.3 Bayer Liquid Formulations Drug Delivery Introduction
11.18.4 Bayer Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.18.5 Bayer Recent Development
11.19 Viatris
11.19.1 Viatris Company Detail
11.19.2 Viatris Business Overview
11.19.3 Viatris Liquid Formulations Drug Delivery Introduction
11.19.4 Viatris Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.19.5 Viatris Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Liquid Formulations Drug Delivery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 136
USD 3950.00
(Single User License)
The global market for Liquid Formulations Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 99
USD 2900.00
(Single User License)
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
The global market for Liquid Formulations Drug Delivery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 136
The global market for Liquid Formulations Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 99
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
Published: 2024-04-10
Pages: 112
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now